The European Society for Medical Oncology announced the creation of a new award honoring individuals for achievements in cancer immunotherapy. The award will be presented at ESMO’s newly launched Immuno-Oncology Congress in Geneva this December.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
